Literature DB >> 4367487

Properties of the ts3 mutant of polyoma virus during lytic infection.

W Eckhart, R Dulbecco.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4367487     DOI: 10.1016/0042-6822(74)90331-6

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  8 in total

1.  A consideration of the role of cell surface macromolecules in the process of viral transformation.

Authors:  R Sheinin; C Shopsis
Journal:  In Vitro       Date:  1976-03

2.  Deficiency in histone acetylation in nontransforming host range mutants of polyoma virus.

Authors:  B S Schaffhausen; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

3.  Construction of the genetic map of the polyoma genome.

Authors:  L K Miller; M Fried
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

4.  BALB/3T3 cells infected by the ts3 mutant of polyoma virus fail to accumulate virus-specific early RNA at the nonpermissive temperature.

Authors:  B Cogen; W Eckhart
Journal:  J Virol       Date:  1977-11       Impact factor: 5.103

5.  DNA synthesis and template activity in a mutant of polyoma virus with altered expression of late viral proteins.

Authors:  C Blackburn; J D Hare
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

6.  Molecular genetics of herpes simplex virus. VI. Characterization of a temperature-sensitive mutant defective in the expression of all early viral gene products.

Authors:  D M Knipe; W Batterson; C Nosal; B Roizman; A Buchan
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

7.  Mutation affecting late gene expression in polyoma virus maps in the late region.

Authors:  E K Thomas; J D Hare
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

8.  Localization of gene functions in polyoma virus DNA.

Authors:  J Feunteun; L Sompayrac; M Fluck; T Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.